Bönnemann CG Wang CH Quijano-Roy S Deconinck N Bertini E Ferreiro A et al.

Diagnostic approach to the congenital muscular dystrophies.

Neuromuscul Disord. 2014; 24: 289-311https://doi.org/10.1016/j.nmd.2013.12.011Incecik F Herguner OM Ceylaner S Altunbasak S.

Merosin-negative congenital muscular dystrophy: Report of five cases.

J Pediatr Neurosci. 2015; 10: 346-349https://doi.org/10.4103/1817-1745.174432Zambon AA Ridout D Main M Mein R Phadke R Muntoni F et al.

LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort.

Ann Clin Transl Neurol. 2020; 7: 1870-1882https://doi.org/10.1002/acn3.51172Cejas CP Serra MM Galvez DFG Cavassa EA Taratuto AL Vazquez GA et al.

Muscle MRI in pediatrics: clinical, pathological and genetic correlation.

Pediatr Radiol. 2017; 47: 724-735https://doi.org/10.1007/s00247-016-3777-6Quijano-Roy S Avila-Smirnow D Carlier RY.

Merosin deficient CMD.

in: Wattjes MP Fischer D Neuromuscular Imaging. Springer, Verlag New York2013: 179-183https://doi.org/10.1007/978-1-4614-6552-2Fu J Zheng YM Jin SQ Yi JF Liu XJ Lyn H et al.

Target” and “sandwich” signs in thigh muscles have high diagnostic values for collagen VI-related myopathies.

Chin Med J (Engl). 2016; 129: 1811-1816https://doi.org/10.4103/0366-6999.186638Carlier RY Quijano-Roy S.

Myoimaging in Congenital Myopathies.

Semin Pediatr Neurol. 2019; 29: 30-43https://doi.org/10.1016/j.spen.2019.03.019Yin L Xie ZY Xu HY Zheng SS Wang ZX Xiao JX et al.

T2 mapping and fat quantification of thigh muscles in children with Duchenne muscular dystrophy.

Curr Med Sci. 2019; 39: 138-145https://doi.org/10.1007/s11596-019-2012-8Li W Zheng Y Zhang W Wang Z Xiao J Yuan Y.

Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study.

Neuromuscul Disord. 2015; 25: 375-380https://doi.org/10.1016/j.nmd.2015.01.003Polavarapu K Manjunath M Preethish-Kumar V Sekar D Vengalil S Thomas P et al.

Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.

Neuromuscul Disord. 2016; 26: 768-774https://doi.org/10.1016/j.nmd.2016.09.002Leung DG Carrino JA Wagner KR Jacobs MA.

Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.

Muscle Nerve. 2015; 52: 512-520https://doi.org/10.1002/mus.24569Gerevini S Scarlato M Maggi L Cava M Caliendo G Pasanisi B et al.

Muscle MRI findings in facioscapulohumeral muscular dystrophy.

Eur Radiol. 2016; 26: 693-705https://doi.org/10.1007/s00330-015-3890-1

Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

J Neurol. 2017; 264: 1320-1333https://doi.org/10.1007/s00415-016-8350-6Fatehi F Salort-Campana E Le Troter A Lareau-Trudel E Bydder M Fouré A et al.

Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.

PLOS ONE. 2017; 12e0183825https://doi.org/10.1371/journal.pone.0183825Schramm N Weckbach S Eustace S Long N.

Whole-Body MRI for evaluation of the entire muscular system.

in: Weber MA Magnetic resonance imaging of the skeletal musculature. Springer-Verlag, Berlin2013: 55-68Díaz-Manera J Llauger J Gallardo E Illa I.

Muscle MRI in muscular dystrophies.

Acta Myol. 2015; 34: 95-108Fischer D Kley RA Strach K Meyer C Sommer T Eger K et al.

Distinct muscle imaging patterns in myofibrillar myopathies.

Neurology. 2008; 71: 758-765https://doi.org/10.1212/01.wnl.0000324927.28817.9bRehmann R Froeling M Rohm M Forsting J Kley RA Schmidt-Wilcke T et al.

Diffusion tensor imaging reveals changes in non-fat infiltrated muscles in late onset Pompe disease.

Muscle & Nerve. 2020; 62: 541-549https://doi.org/10.1002/mus.27021Liang Y Li G Chen S He R Zhou X Chen Y et al.

Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.

Biomed Rep. 2017; 7: 193-196https://doi.org/10.3892/br.2017.935Fahmy N EL-Sobky T Elsayed N Sakr H Saadawy A.

Whole-body muscle magnetic resonance imaging characteristics of children with merosin-deficient congenital muscular dystrophy.

Dev Med Child Neurol. 2018; 60: 94-95https://doi.org/10.1111/dmcn.29_14018Fahmy N EL-Sobky T Elsayed N Sakr H Saadawy A.

Whole-body muscle magnetic resonance imaging characteristics of children with merosin-deficient congenital muscular dystrophy [Poster presentation].

in: Transformative Journeys. (2018, October 9-13); 72nd Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine, Cincinnati, Ohio, United States2021Tordjman M Dabaj I Laforet P Felter A Ferreiro A Biyoukar M et al.

Muscular MRI-based algorithm to differentiate inherited myopathies presenting with spinal rigidity.

Eur Radiol. 2018; 28: 5293-5303https://doi.org/10.1007/s00330-018-5472-5Tasca G Monforte M Iannaccone E Laschena F Ottaviani P Leoncini E et al.

Upper girdle imaging in facioscapulohumeral muscular dystrophy.

PLoS ONE. 2014; 9e100292https://doi.org/10.1371/journal.pone.0100292Mercuri E Pichiecchio A Allsop J Messina S Pane M Muntoni F.

Muscle MRI in inherited neuromuscular disorders: Past, present, and future.

J Magn Reson Imaging. 2007; 25: 433-440https://doi.org/10.1002/jmri.20804Bing Q Hu K Tian Q Zhao Z Shen H Li N et al.

Semi-quantitative assessment of lower limb MRI in dystrophinopathy.

Int J Clin Exp Med. 2016; 9: 13723-13732Brogna C Cristiano L Verdolotti T Pichiecchio A Cinnante C Sansone V et al.

MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.

J Neurol. 2020; 267: 898-912https://doi.org/10.1007/s00415-019-09646-wOtto LAM van der Pol WL Schlaffke L Wijngaarde CA Stam M Wadman RI et al.

Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3.

NMR Biomed. 2020; 33: e4357https://doi.org/10.1002/nbm.4357Mercuri E Bushby K Ricci E Birchall D Pane M Kinali M et al.

Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.

Neuromuscul Disord. 2005; 15: 164-171https://doi.org/10.1016/j.nmd.2004.10.008Fischer D Walter MC Kesper K Petersen JA Aurino S Nigro V et al.

Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

J Neurol. 2005; 252: 538-547https://doi.org/10.1007/s00415-005-0684-4Barp A Laforet P Bello L Tasca G Vissing J Monforte M et al.

European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

J Neurol. 2020; 267: 45-56https://doi.org/10.1007/s00415-019-09539-yAllamand V Briñas L Richard P Stojkovic T Quijano-Roy S Bonne G.

ColVI myopathies: Where do we stand, where do we go?.

Skelet Muscle. 2011; 1: 30https://doi.org/10.1186/2044-5040-1-30Sugie K Sugie M Taoka T Tonomura Y Kumazawa A Izumi T et al.

Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1.

PLoS ONE. 2015; 10e0125051https://doi.org/10.1371/journal.pone.0125051Heskamp L van Nimwegen M Ploegmakers MJ Bassez G Deux JF Cumming SA et al.

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.

Neurology. 2019; 92: e2803-e2814https://doi.org/10.1212/WNL.0000000000007648Salim R Dahlqvist JR Khawajazada T Kass K Revsbech KL de Stricker Borch J et al.

Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy.

J Neurol. 2020; 267: 2432-2442https://doi.org/10.1007/s00415-020-09860-xRopars J Gravot F Ben Salem D Rousseau F Brochard S Pons C

Muscle MRI: A biomarker of disease severity in Duchenne muscular dystrophy? A systematic review.

Neurology. 2020; 94: 117-133https://doi.org/10.1212/WNL.0000000000008811Naarding KJ Reyngoudt H van Zwet EW Hooijmans MT Tian C Rybalsky I et al.

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy.

Neurology. 2020; 94: e1386-e1394https://doi.org/10.1212/WNL.0000000000008939Leung DG Bocchieri AE Ahlawat S Jacobs MA Parekh VS Braverman V et al.

Longitudinal functional and imaging outcome measures in FKRP limb-girdle muscular dystrophy.

BMC Neurol. 2020; 20: 196https://doi.org/10.1186/s12883-020-01774-5Willis TA Hollingsworth KG Coombs A Sveen ML Andersen S Stojkovic T et al.

Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study.

PLoS One. 2013; 8: e70993https://doi.org/10.1371/journal.pone.0070993

The limb-girdle muscular dystrophies: is treatment on the horizon?.

Neurotherapeutics. 2018; 15: 849-862https://doi.org/10.1007/s13311-018-0648-xBabačić H Mehta A Merkel O Schoser B.

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.

PLoS One. 2019; 14e0212198https://doi.org/10.1371/journal.pone.0212198